TWI410248B - Extract of leaves of typhonium blumei nicolson & sivadasan and its use - Google Patents

Extract of leaves of typhonium blumei nicolson & sivadasan and its use Download PDF

Info

Publication number
TWI410248B
TWI410248B TW101107225A TW101107225A TWI410248B TW I410248 B TWI410248 B TW I410248B TW 101107225 A TW101107225 A TW 101107225A TW 101107225 A TW101107225 A TW 101107225A TW I410248 B TWI410248 B TW I410248B
Authority
TW
Taiwan
Prior art keywords
extract
soil
extraction
extraction step
ethyl acetate
Prior art date
Application number
TW101107225A
Other languages
Chinese (zh)
Other versions
TW201336501A (en
Inventor
Che Yiing Hung
Chia Fen Hu
Ting Tseng
Original Assignee
Univ Ishou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ishou filed Critical Univ Ishou
Priority to TW101107225A priority Critical patent/TWI410248B/en
Publication of TW201336501A publication Critical patent/TW201336501A/en
Application granted granted Critical
Publication of TWI410248B publication Critical patent/TWI410248B/en

Links

Abstract

The present invention is related to an extract of leaves of Typhonium blumei Nicolson & Sivadasan obtained by a process comprising steps of: first extraction, second extraction and third extraction, in which various extracted reagents including methanol, hexane and ethyl acetate are used respectively for extracting the leaves of Typhonium blumei Nicolson & Sivadasan. The extract of leaves of Typhonium blumei Nicolson & Sivadasan is capable of being used in manufacturing into medical assistants or functional products for improving hypertension and cardiovascular diseases.

Description

土半夏葉萃取物及其用途Soil summer leaf extract and its use

本發明係關於一種植物萃取物及其用途,特別係關於一種土半夏葉萃取物以及其在改善高血壓或心血管疾病等之用途。The present invention relates to a plant extract and its use, and in particular to a soil summer leaf extract and its use for improving hypertension or cardiovascular diseases and the like.

高血壓係現代人類健康的首要威脅,過去數年來,一直高居國人十大死因排行榜,且攸關腦中風、心肌梗塞和糖尿病等重要成人病。高血壓的早期症狀並不顯著,往往被忽略而延誤就醫,以致損及主要器官(如心臟及主動脈),嚴重威脅人類的健康。因此,為了改善現代人高血壓的問題,心臟血管的用藥及開發尤為重視。Hypertension is the primary threat to modern human health. Over the past few years, it has been ranked among the top ten causes of death in the country, and it has been linked to important adult diseases such as stroke, myocardial infarction and diabetes. The early symptoms of hypertension are not significant, and are often ignored and delayed to seek medical treatment, so that damage to major organs (such as the heart and aorta) is a serious threat to human health. Therefore, in order to improve the problem of hypertension in modern people, the administration and development of cardiovascular blood vessels are particularly important.

習用治療高血壓之臨床藥物包含血管收縮素轉化酶抑制劑(angiotensin-converting enzyme inhibitor;ACEi),如卡托普利(Captopril)、依那普利(Enalapril)等,其藥理作用是抑制血管收縮素轉化酶(angiotensin-converting enZyme;ACE)活性,減少血管收縮素II的生成及血管舒張素(bradykinin)的水解,使血管舒張,血容量減少,進而達到血壓下降的作用。The clinical drug for the treatment of hypertension includes angiotensin-converting enzyme inhibitor (ACEi), such as Captopril, Enalapril, etc., and its pharmacological action is to inhibit vasoconstriction. Angiotensin-converting enZyme (ACE) activity reduces the production of angiotensin II and the hydrolysis of bradykinin, which causes vasodilation and blood volume to decrease, thereby achieving a blood pressure drop.

具有ACEi活性食品之開發,為近年來新興的研發潮流,目前已有文獻報導食物蛋白之水解物,如玉米蛋白(Miyoshi et al.,1991)、魚肉蛋白(Matsui et al.,1993;Nakajima et al.,2009)、大豆蛋白(Wu et al.,2002)與諾力果(Yamaguchi et al.,2002)等,皆為具抑制ACE活性之機能性食品;另外,在中草藥方面,冬凌草(Rabdosia coetsa)、竹茹(Bambusae caulis)、深海褐藻(Ecklonia cava)、歐洲女貞(Ligustrum vulgare L.)、百子蓮(Agapanthus africanus)、黃邊龍舌蘭(Agave americana)、黃皮屬茴香(Clausena anisata)、鳶尾花(Dietes iridioides)及紫嬌花(Tulbaghia violacea)等皆具有ACEi之功效(Li et al.,2008,Phytomedicine 15:386-388;Je et al.,2009,Food Chem.,113: 932-935;Wijesinghe et al.,2011,Nutrition Research and Practice 5(2): 93-100;Kiss et al.,2008. Journal of Ethnopharmacology 120(2): 220-225)。The development of ACEi-active foods has been an emerging trend in recent years. There have been reports of hydrolysates of food proteins such as zein (Miyoshi et al., 1991) and fish protein (Matsui et al., 1993; Nakajima et Al., 2009), soy protein (Wu et al., 2002) and noodle fruit (Yamaguchi et al., 2002), etc., all of which are functional foods that inhibit ACE activity; in addition, in Chinese herbal medicine, weeds (Rabdosia coetsa), Bambusae caulis, Ecklonia cava, Ligustrum vulgare L., Agapanthus africanus, Agave americana, yellow fennel (Clausena anisata), Dietes iridioides, and Tulbaghia violacea all have the effect of ACEi (Li et al., 2008, Phytomedicine 15: 386-388; Je et al., 2009, Food Chem. 113: 932-935; Wijesinghe et al., 2011, Nutrition Research and Practice 5(2): 93-100; Kiss et al., 2008. Journal of Ethnopharmacology 120(2): 220-225).

然而,由前述各種ACEi活性食品或中草藥中雖具有抑制ACE的活性成分,其抑制效果卻往往不佳,或無法有效率地分離、萃取而使其應用層面因而受限。However, in the above-mentioned various ACEI active foods or Chinese herbal medicines, although the active ingredient which inhibits ACE, the inhibitory effect is often poor, or it cannot be separated and extracted efficiently, and the application level is limited.

故,有必要進一步開發具有ACEi活性的天然草本植物,應用於降血壓藥的開發,以有效改善提升國人高血壓的問題。Therefore, it is necessary to further develop natural herbaceous plants with ACEi activity, which are applied to the development of blood pressure lowering drugs, so as to effectively improve the problem of improving hypertension in Chinese people.

土半夏(Typhonium blumei Nicolson & Sivadasan),為天南星科(Araceae)、土半夏屬(Typhonium)之草本植物。土半夏為傳統民俗用草藥,其習用用途係作為解毒劑或用於跌打損傷及腫毒之外敷藥,具散瘀、止血、消腫、解毒等療效。土半夏葉片味辛、性溫,內服主治各種癌症、肝硬化及無名腫毒,但在抑制ACE活性方面則尚無任何報導與應用。 Typhonium blumei Nicolson & Sivadasan is a herbaceous plant of Araceae and Typhonium. Pinellia ternata is a traditional folklore herb, and its conventional use is used as an antidote or as a dressing for bruises and swelling, with dilatation, hemostasis, swelling, and detoxification. The leaves of Pinellia ternata are spicy and warm, and they are used to treat various cancers, cirrhosis and unknown swollen poisons. However, there is no report or application in inhibiting ACE activity.

本發明之主要目的係提供一種土半夏葉萃取物,係具有良好的血管收縮素轉化酶抑制劑活性,且便於萃取、分離而可應用於降血壓製劑或相關保健食品之開發。The main object of the present invention is to provide a soil semi-summer leaf extract which has good angiotensin-converting enzyme inhibitor activity and is convenient for extraction and separation and can be applied to the development of a blood pressure lowering preparation or related health food.

本發明之次一目的係提供土半夏葉萃取物在改善高血壓、心血管疾病等之用途,係將前述之土半夏葉萃取物作為一活性成分,應用於降血壓輔助治療劑或相關保健食品之開發。The second object of the present invention is to provide the use of the extract of Pinellia ternata in improving blood pressure, cardiovascular diseases and the like, and the above-mentioned soil extract of Pinellia ternata as an active ingredient, which is applied to a blood pressure lowering auxiliary therapeutic agent or related health food. Development.

為達到前述發明目的,本發明所運用之技術內容包含有:一種土半夏葉萃取物,係藉由一包含下列步驟之方法所製得:一第一萃取步驟,係使用乙醇作為萃取溶劑,對土半夏葉進行萃取處理,使該土半夏葉與該乙醇之重量體積比(w/v,g/ml)為1:4至1:10,並回收乙醇萃取液,再濃縮該乙醇萃取液而獲得一第一萃取物;一第二萃取步驟,係使用等體積之乙醇與正己烷作為萃取溶劑,對該第一萃取步驟所得之第一萃取物進行萃取處理,靜置分層後取乙醇層,經減壓濃縮與冷凍乾燥而獲得一第二萃取物,其中,該第一萃取物與該第二萃取步驟萃取溶劑之重量體積比為1:1至1:10;及一第三萃取步驟,係於該第二萃取物中加入等體積之水與乙酸乙酯作為萃取溶劑,對該第二萃取物進行萃取處理,靜置分層後取乙酸乙酯層,經減壓濃縮與冷凍乾燥而獲得該土半夏葉萃取物,其中,該第二萃取物與萃取溶劑之重量體積比為1:1至1:10。In order to achieve the foregoing object, the technical content of the present invention comprises: a soil summer leaf extract obtained by a method comprising the following steps: a first extraction step using ethanol as an extraction solvent, The soil summer leaves are subjected to extraction treatment so that the weight-to-volume ratio (w/v, g/ml) of the soil to the ethanol is 1:4 to 1:10, and the ethanol extract is recovered, and the ethanol extract is concentrated. Obtaining a first extract; and a second extracting step, using an equal volume of ethanol and n-hexane as an extraction solvent, extracting the first extract obtained in the first extraction step, and separating the layer to obtain an ethanol layer And concentrating under reduced pressure and lyophilizing to obtain a second extract, wherein the weight ratio of the first extract to the second extraction step extraction solvent is 1:1 to 1:10; and a third extraction step The second extract is added with an equal volume of water and ethyl acetate as an extraction solvent, and the second extract is subjected to extraction treatment, and the layer is separated, and the ethyl acetate layer is taken, and concentrated under reduced pressure and freeze-dried. Obtaining the soil Wherein the second extract with a volume ratio of extraction solvent weight ratio of 1: 1 to 1:10.

本發明之土半夏葉萃取物,其中,該方法更包含一管柱層析步驟,係於該第三萃取步驟之後操作,將該第三萃取步驟之土半夏葉萃取物,利用一矽膠管柱,依序以正己烷和乙酸乙酯,以及乙酸乙酯和甲醇作為流動相,進行層析分離處理,分瓶收集洗滌液,再以薄膜色層分析該洗滌液,合併成份相同之洗滌液,以獲得數個區分物,該區分物係依洗滌先後而編號為Fr.1至Fr.10,擷選該Fr.10經減壓濃縮及冷凍乾燥後,即得該土半夏葉萃取物。The soil summer leaf extract of the present invention, wherein the method further comprises a column chromatography step, after the third extraction step, the third extraction step of the soil, the summer leaf extract, using a rubber tube column Then, using n-hexane and ethyl acetate, and ethyl acetate and methanol as mobile phases, chromatographic separation treatment, collecting the washing liquid in a separate bottle, and analyzing the washing liquid by a film color layer, and combining the washing liquids having the same composition. Several fractions were obtained, which were numbered as Fr.1 to Fr.10 according to the washing sequence, and the Fr.10 was concentrated under reduced pressure and freeze-dried to obtain the soil summer leaf extract.

本發明之土半夏葉萃取物,其中,該管柱層析步驟,係擷選該Fr.2經減壓濃縮及冷凍乾燥後,即得該土半夏葉萃取物。The soil summer leaf extract of the present invention, wherein the column chromatography step is performed by selecting the Fr. 2 to concentrate under reduced pressure and freeze-drying, thereby obtaining the soil summer leaf extract.

本發明之土半夏葉萃取物,其中,該管柱層析步驟中,係利用不同比例正己烷和乙酸乙酯混合液,其中該正己烷與該乙酸乙酯的混合比例由100%正己烷,依序以每次10%之比例逐漸改變為1:9,接著以不同比例乙酸乙酯和甲醇混合液作為流動相,其中該乙酸乙酯和甲醇的混合比例由100%乙酸乙酯,依序以每次10%之比例逐漸改變比例至100%甲醇,以進行層析區分分離。The soil summer leaf extract of the present invention, wherein the column chromatography step utilizes a mixture of different ratios of n-hexane and ethyl acetate, wherein the ratio of the n-hexane to the ethyl acetate is 100% n-hexane. Gradually change to 1:9 in a ratio of 10% each time, followed by a mixture of ethyl acetate and methanol in different proportions as a mobile phase, wherein the mixing ratio of ethyl acetate and methanol is 100% ethyl acetate, in order The ratio was gradually changed to 100% methanol at a rate of 10% each time for chromatographic separation.

本發明之土半夏葉萃取物,其中,各比例之流動相係以500毫升之體積依序通入該矽膠管柱,再於該矽膠管柱下方分瓶收集洗滌液,每瓶所收的洗滌液量為250毫升。The soil summer leaf extract of the present invention, wherein the mobile phase of each ratio is sequentially introduced into the rubber tube column in a volume of 500 ml, and the washing liquid is collected in a bottle under the rubber tube column, and the washing liquid is collected in each bottle. The amount of liquid is 250 ml.

本發明之土半夏葉萃取物,其中該第一萃取步驟之萃取溶劑係50%至95%之乙醇。The soil summer leaf extract of the present invention, wherein the extraction solvent of the first extraction step is 50% to 95% ethanol.

本發明之土半夏葉萃取物,其中,該第一萃取步驟、第二萃取步驟及第三萃取步驟係操作於攪拌速率為100至1000 rpm、25℃至70℃之環境,重覆萃取1至3次,每次萃取30分鐘以上。The soil summer leaf extract of the present invention, wherein the first extraction step, the second extraction step and the third extraction step are operated at an agitation rate of 100 to 1000 rpm, 25 ° C to 70 ° C, and repeated extraction 1 to 3 times, each extraction for more than 30 minutes.

本發明之土半夏葉萃取物,其中,該第一萃取步驟係重複萃取3次且每次萃取24小時。The soil summer leaf extract of the present invention, wherein the first extraction step is repeated 3 times and extracted for 24 hours each time.

本發明之土半夏葉萃取物,其中,該第二萃取步驟係重複萃取3次且每次萃取3小時。The soil summer leaf extract of the present invention, wherein the second extraction step is repeated 3 times and extracted for 3 hours each time.

本發明之土半夏葉萃取物,其中,該第三萃取步驟係重複萃取3次且每次萃取3小時。The soil summer leaf extract of the present invention, wherein the third extraction step is repeated 3 times and extracted for 3 hours each time.

以及,本發明之土半夏葉萃取物的用途,係將該土半夏葉萃取物作為一活性物質,應用於製備用以改善高血壓的輔助治療劑或保健食品。Further, the use of the soil summer leaf extract of the present invention is the use of the soil summer leaf extract as an active substance for the preparation of an adjuvant therapeutic or health food for improving hypertension.

為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下:The above and other objects, features and advantages of the present invention will become more <RTIgt;

請參照第1圖所示,本發明第一實施例之土半夏葉萃取物,係藉由一包含下列步驟之方法所製得:一第一萃取步驟S1,一第二萃取步驟S2以及一第三萃取步驟S3。Referring to FIG. 1 , the soil summer leaf extract of the first embodiment of the present invention is obtained by a method comprising the following steps: a first extraction step S1, a second extraction step S2 and a first Three extraction steps S3.

本發明之第一萃取步驟S1,係使用乙醇作為萃取溶劑,對土半夏葉進行萃取處理,使該土半夏葉與該乙醇之重量體積比(w/v,g/ml)為1:4至1:10,並回收乙醇萃取液,再濃縮該乙醇萃取液而獲得一第一萃取物。更詳言之,該第一萃取步驟S1係先準備新鮮土半夏葉,經液態氮凍乾後利用研缽搗碎,該第一萃取步驟S1係使用50%至95%之乙醇為萃取溶劑,於攪拌速率為100至1000 rpm、25至70℃之環境下萃取30分鐘以上,且重覆萃取1至3次,較佳係萃取24小時且重複萃取3次,回收得一乙醇萃取液。該乙醇萃取液係進一步使用一減壓濃縮機進行萃取溶劑的移除,再使用一冷凍乾燥機進行乾燥處理,而獲得該第一萃取物。The first extraction step S1 of the present invention uses ethanol as an extraction solvent to extract the soil of Pinellia ternata, so that the weight-to-volume ratio (w/v, g/ml) of the soil to the ethanol is 1:4. 1:10, and the ethanol extract was recovered, and the ethanol extract was concentrated to obtain a first extract. In more detail, the first extraction step S1 is to prepare fresh soil Pinellia ternata, and after lyophilization by liquid nitrogen, the mash is used, and the first extraction step S1 uses 50% to 95% ethanol as an extraction solvent. The extraction is carried out for 30 minutes or more at an agitation rate of 100 to 1000 rpm, 25 to 70 ° C, and repeated extraction 1 to 3 times, preferably for 24 hours and repeated extraction 3 times, to recover an ethanol extract. The ethanol extract is further subjected to removal of an extraction solvent using a vacuum condenser, and then dried using a freeze dryer to obtain the first extract.

該第二萃取步驟S2,係使用等體積之乙醇與正己烷作為萃取溶劑,對該第一萃取步驟S1所得之第一萃取物進行萃取處理,靜置分層後取乙醇層,經減壓濃縮及冷凍乾燥處理以獲得一第二萃取物,其中,該第一萃取物與萃取溶劑之重量體積比為1:1至1:10。更詳言之,該第二萃取步驟S2於該第一萃取物中,加入等體積之乙醇及正己烷作為萃取溶劑,並於攪拌速率為100至1000 rpm、25℃至70℃之環境下萃取30分鐘以上,且重覆萃取1至3次,較佳係萃取3小時且重複萃取3次,待靜置分層後,分別收集上方的正己烷層及下方的乙醇層,該正己烷層經減壓濃縮及冷凍乾燥處理即可獲得一正己烷萃取物;該乙醇層經減壓濃縮及冷凍乾燥處理即可獲得該第二萃取物。The second extraction step S2 uses an equal volume of ethanol and n-hexane as an extraction solvent, and the first extract obtained in the first extraction step S1 is subjected to extraction treatment, and after standing and layering, an ethanol layer is taken and concentrated under reduced pressure. And lyophilizing to obtain a second extract, wherein the weight ratio of the first extract to the extraction solvent is 1:1 to 1:10. More specifically, the second extraction step S2 is carried out in the first extract by adding an equal volume of ethanol and n-hexane as an extraction solvent, and extracting at an agitation rate of 100 to 1000 rpm and 25 to 70 ° C. More than 30 minutes, and repeated extraction 1 to 3 times, preferably 3 hours of extraction and repeated extraction 3 times, after standing and layering, separately collect the upper n-hexane layer and the lower ethanol layer, the n-hexane layer The n-hexane extract can be obtained by concentration under reduced pressure and freeze-drying; the ethanol layer is concentrated under reduced pressure and freeze-dried to obtain the second extract.

該第三萃取步驟S3,係取該第二萃取物,加入等體積之水與乙酸乙酯作為萃取溶劑進行萃取處理,其中,該第二萃取物與萃取溶劑之重量體積比為1:1至1:10;靜置分層後取乙酸乙酯層,再濃縮該乙酸乙酯層而獲得該土半夏葉萃取物。更詳言之,該第三萃取步驟S3係收集該第二萃取步驟S2所獲得之該第二萃取物,加入等體積的水與乙酸乙酯作為萃取溶劑,並且在攪拌速率為100至1000 rpm,溫度為25℃至70℃之環境下萃取30分鐘以上,且重覆萃取1至3次,較佳係萃取3小時且重複萃取3次,待靜置分層後,取上方乙酸乙酯層,利用減壓濃縮機將萃取溶劑移除,再經冷凍乾燥而得到該第一實施例的土半夏葉萃取物。The third extraction step S3, the second extract is taken, and an equal volume of water and ethyl acetate are added as an extraction solvent for extraction treatment, wherein the weight ratio of the second extract to the extraction solvent is 1:1 to 1:10; After standing to separate the layers, an ethyl acetate layer was taken, and the ethyl acetate layer was concentrated to obtain a soil extract of Pinellia ternata. More specifically, the third extraction step S3 collects the second extract obtained in the second extraction step S2, adding an equal volume of water and ethyl acetate as an extraction solvent, and stirring at a rate of 100 to 1000 rpm. , the extraction temperature is 25 ° C to 70 ° C environment for more than 30 minutes, and repeated extraction 1 to 3 times, preferably for 3 hours and repeated extraction 3 times, after standing layering, take the upper ethyl acetate layer The extractive solvent of the first embodiment was obtained by removing the extraction solvent by a reduced pressure concentrator and then lyophilizing.

本發明的土半夏葉萃取物係藉由前述之方法,進行溶劑萃取之處理,取得該土半夏葉中具有血管收縮素轉化酶抑制劑活性的活性成分,而可進一步應用於高血壓輔助治療劑或保健食品之開發。請參照第1表所示,係二萃取物樣品的產率及血管收縮素轉化酶抑制劑活性分析,其中,該正己烷萃取物係於前述之第二萃取步驟S2中所收集且經冷凍乾燥處理而獲得之正己烷萃取物;該土半夏葉萃取物即為本發明第一實施例之土半夏葉萃取物。The soil semi-summer leaf extract of the present invention is subjected to solvent extraction treatment by the aforementioned method to obtain an active ingredient having an angiotensin-converting enzyme inhibitor activity in the soil, and can be further applied to a blood pressure auxiliary therapeutic agent. Or the development of health food. Please refer to the first table for the yield of the two extract samples and the angiotensin-converting enzyme inhibitor activity analysis, wherein the n-hexane extract is collected in the second extraction step S2 and freeze-dried. The n-hexane extract obtained by the treatment; the soil pinellia leaf extract is the soil summer leaf extract of the first embodiment of the present invention.

其中,75微升(μl)之土半夏葉萃取物及正己烷萃取物係分別與75微升(μl)血管收縮素轉化酶酵素液(Angiotensin Converting Enzyme form rabbit lung,ACE;Sigma Chemicals)充分混合,在37℃水浴下靜置10分鐘後,加入75微升(μl) HHL基質液(Hippuryl-His-Leu acetate salt,HHL;Sigma Chemicals)在37℃水浴下反應30分鐘,最後再加入1 N鹽酸(HCl)終止反應。各樣品經反應後所生成的馬尿酸(Hippuric acid;HA),係利用以750微升(μl)之乙酸乙酯作為萃取溶劑,進行萃取處理,再於震盪1分鐘後以3600 rpm之轉速離心5分鐘,取離心後的上清液500微升(μl)。該上清液經80℃水浴蒸乾,加入1毫升(ml)去離子水回溶,最後利用一分光光度計以波長228 nm測吸光值,所得結果進一步帶入公式1,計算各樣品對於該血管收縮素轉化酶的抑制能力。Among them, 75 μl of soil Pinellia ternata extract and n-hexane extract were thoroughly mixed with 75 μl of angiotensin Converting Enzyme form rabbit lung (ACE; Sigma Chemicals). After standing at 37 ° C for 10 minutes in a water bath, 75 μl of (μl) HHL substrate solution (Hippuryl-His-Leu acetate salt, HHL; Sigma Chemicals) was added to react in a 37 ° C water bath for 30 minutes, and finally 1 N was added. The reaction was terminated with hydrochloric acid (HCl). The hippuric acid (HA) produced by the reaction of each sample was extracted with 750 μl of ethyl acetate as an extraction solvent, and then centrifuged at 3,600 rpm for 1 minute after shaking. Five minutes, 500 μl (μl) of the supernatant after centrifugation was taken. The supernatant was evaporated to dryness in a water bath at 80 ° C, and dissolved in 1 ml (ml) of deionized water. Finally, the absorbance was measured by a spectrophotometer at a wavelength of 228 nm, and the obtained result was further brought into Formula 1, and each sample was calculated for the sample. Inhibitory ability of angiotensin converting enzyme.

公式1:抑制能力(%)=[(Ac-As)/(Ac-Ab)]×100%;其中As表示前述各萃取物樣品反應後所測得之吸光值、Ac表示以緩衝溶液取代萃取物樣品反應後所測得之吸光值、Ab表示各萃取物樣品反應前加入鹽酸終止反應再依相同檢測步驟所測得的吸光值。本發明乃係以IC50 值作為血管收縮素轉化酶抑制劑的活性指標,該IC50 值的意義在於所測萃取物樣品能抑制50%該血管收縮素轉化酶活性之樣品濃度。先以一緩衝溶液或溶劑,如DMSO(dimethyl sulfoxide)將待測之萃取物樣品稀釋至不同濃度,以上述方法測定其該血管收縮素轉化酶的抑制能力後,求出其統計迴歸線圖,並依此迴歸方程式求得抑制50%該血管收縮素轉化酶活性時所需之萃取物樣品濃度。Formula 1: Inhibition ability (%) = [(Ac-As) / (Ac-Ab)] × 100%; where As represents the absorbance measured after the reaction of each of the above extract samples, and Ac represents the extraction by buffer solution instead of extraction The absorbance measured after the reaction of the sample of the substance, Ab represents the absorbance value measured by the same detection step after adding the hydrochloric acid to terminate the reaction before each sample of the extract. The present invention is based on the IC 50 value as an activity index of an angiotensin-converting enzyme inhibitor, and the significance of the IC 50 value is that the measured extract sample can inhibit the sample concentration of the angiotensin converting enzyme activity by 50%. First, the sample of the extract to be tested is diluted to a different concentration with a buffer solution or a solvent such as DMSO (dimethyl sulfoxide), and the inhibition ability of the angiotensin-converting enzyme is determined by the above method, and the statistical regression line is obtained. Based on this regression equation, the concentration of the extract sample required to inhibit 50% of the angiotensin-converting enzyme activity was determined.

第1表:萃取物樣品之產率及ACEi活性Table 1: Yield and ACEI activity of extract samples

由該第1表結果所示之IC50 值,可得知本發明第一實施例之土半夏葉萃取物確實具有抑制血管收縮素轉化酶的活性。From the IC 50 value shown in the results of the first table, it was found that the soil summer leaf extract of the first embodiment of the present invention did have an activity of inhibiting angiotensin converting enzyme.

請參照第2圖所示,其為不同濃度之土半夏葉萃取物(本發明第一實施例之土半夏葉萃取物)對血管收縮素轉化酶活性之影響,並可由其迴歸線計算出其IC50 值為494.4 μg/ml。Please refer to FIG. 2, which is the effect of different concentrations of soil Pinellia ternata extract (the first summer leaf extract of the first embodiment of the present invention) on angiotensin-converting enzyme activity, and its IC can be calculated from its regression line. The 50 value is 494.4 μg/ml.

請參照第3圖所示,為本發明第二實施例之土半夏葉萃取物,係藉由一包含下列步驟之方法所製得:一第一萃取步驟S4,一第二萃取步驟S5、一第三萃取步驟S6以及一管柱層析步驟S7。Referring to FIG. 3, the soil summer leaf extract of the second embodiment of the present invention is obtained by a method comprising the following steps: a first extraction step S4, a second extraction step S5, and a first extraction step S5. The third extraction step S6 and a column chromatography step S7.

其中,該第一、第二及第三萃取步驟S4、S5、S6與製得該第一實施例之土半夏葉萃取物的第一、第二及第三萃取步驟S1、S2、S3並無不同,故不再贅述。Wherein the first, second and third extraction steps S4, S5, S6 and the first, second and third extraction steps S1, S2, S3 for preparing the soil summer leaf extract of the first embodiment are not Different, so no longer repeat them.

該層析步驟S7,係將該土半夏葉萃取物,利用一矽膠管柱,依序以不同比例正己烷和乙酸乙酯,以及不同比例乙酸乙酯和甲醇作為流動相,進行層析分離處理,分瓶收集洗滌液,再以薄膜色層分析該洗滌液,合併成份相同之洗滌液,以獲得數個區分物,該區分物經減壓濃縮及冷凍乾燥後,即得本發明第二實施例之土半夏葉萃取物。其中,該薄膜色層分析係以比例為6:4之正己烷和乙酸乙酯混合液或100%甲醇為移動相,進行各瓶洗滌液之成份分析,據此將含有相同成份之洗滌液合併,而獲得該數個區分物。The chromatography step S7 is carried out by using a tantalum rubber tube column, using a ruthenium rubber column, sequentially using different ratios of n-hexane and ethyl acetate, and different ratios of ethyl acetate and methanol as mobile phases for chromatographic separation treatment. The washing liquid is collected in a divided bottle, and the washing liquid is analyzed by a film color layer, and the washing liquids having the same composition are combined to obtain a plurality of parts, and the parts are concentrated under reduced pressure and freeze-dried to obtain the second embodiment of the present invention. Example soil Pinellia leaf extract. Wherein, the film color layer analysis is carried out by using a mixture of n-hexane and ethyl acetate in a ratio of 6:4 or 100% methanol as a mobile phase, and analyzing the components of each bottle of washing liquid, thereby merging the washing liquids containing the same components. And obtain the plurality of distinctions.

更詳言之,該管柱層析步驟S7係先選用長度為73公分(cm)、管徑寬度為6公分(cm)的矽膠管柱,以一矽膠體(silica gel;Ultra Pure Silica Gel,particle size 230-400 mesh,40-63 um pore size,Silicycle Chemical Division,Canada)作為固定相,利用不同比例正己烷和乙酸乙酯混合液作為流動相,其中該正己烷與該乙酸乙酯的混合比例由100%正己烷,依序以每次10%之比例逐漸改變為1:9,接著以不同比例乙酸乙酯和甲醇混合液作為流動相,其中該乙酸乙酯和甲醇的混合比例由100%乙酸乙酯,依序以每次10%之比例逐漸改變比例至100%甲醇,以進行層析區分分離。其中,各比例之流動相係各以500毫升(ml)逐一依序通入該矽膠管柱內,使用每分鐘約下降2.5公分(cm)的流速,於該矽膠管柱下方出口處分瓶收集洗滌液,每瓶所收的洗滌液量為250毫升(ml)。各瓶洗滌液經薄膜色層分析及合併後,共獲得10個區分物,依洗滌先後編號為Fr.1至Fr.10,該區分物經減壓濃縮及冷凍乾燥後,即為本發明第二實施例之土半夏葉萃取物。More specifically, the column chromatography step S7 is a silica gel column with a length of 73 cm (cm) and a tube diameter of 6 cm (cm), which is a silica gel; Ultra Pure Silica Gel. Particle size 230-400 mesh, 40-63 um pore size, Silicycle Chemical Division, Canada) as a stationary phase, using a mixture of different ratios of n-hexane and ethyl acetate as the mobile phase, wherein the mixture of n-hexane and the ethyl acetate The ratio is gradually changed from 100% n-hexane to 10% in the ratio of 1:9, followed by a mixture of ethyl acetate and methanol in different proportions, wherein the mixing ratio of ethyl acetate and methanol is 100. Ethyl acetate was gradually changed to 100% methanol in a ratio of 10% each for separation by chromatography. Wherein, the mobile phases of each ratio are sequentially introduced into the cartridge column in 500 ml (ml), and the flow rate is decreased by about 2.5 cm (min) per minute, and the bottle is collected and washed at the outlet below the cartridge column. The amount of washing liquid received per bottle was 250 ml (ml). After the film color layer analysis and combination, a total of 10 distinguishing substances were obtained, which were numbered as Fr.1 to Fr.10 according to the washing sequence. After the concentration was concentrated under reduced pressure and freeze-dried, it was the first invention. The soil of the second embodiment of the Pinellia ternata extract.

本實施例較佳係分別擷取該數個區分物中,編號為Fr.2、Fr.10或其組合之區分物,再經減壓濃縮及冷凍乾燥而獲得之土半夏葉萃取物,該土半夏葉萃取物可具有較佳之抑制血管收縮素轉化酶活性。In this embodiment, the extracts of the plurality of different parts, numbered as Fr. 2, Fr. 10 or a combination thereof, and the soil of the summer leaves obtained by concentration under reduced pressure and freeze-dried are preferably taken. The soil summer leaf extract can preferably inhibit angiotensin converting enzyme activity.

請參照第2表所示,為前述各區分物對抑制血管收縮素轉化酶活性之IC50 值,其中以編號Fr.10區分物之抑制活性最佳,其結果顯示該第二實施例之區分物Fr.10與Fr.2確實具有血管收縮素轉化酶抑制劑之活性,該區分物經減壓濃縮及冷凍乾燥後可以應用於降血壓輔助治療劑或相關保健食品的開發與製備,以改善國人高血壓的問題。本實施例之血管收縮素轉化酶抑制劑活性分析,與該第一實施例的操作方法相同,並且帶入該公式1計算。請參照第4圖所示,其為不同濃度之區分物Fr.10樣品對血管收縮素轉化酶活性之影響,並可由其迴歸線計算出其IC50 值為383.7 μg/ml。Referring to Table 2, the IC 50 value for inhibiting angiotensin-converting enzyme activity of each of the above-mentioned different substances is the best, and the inhibitory activity of the No. Fr. 10 is the best, and the result shows the distinction of the second embodiment. The Fr.10 and Fr.2 do have the activity of an angiotensin-converting enzyme inhibitor, and the fraction can be applied to the development and preparation of a blood pressure-lowering auxiliary therapeutic agent or related health food after being concentrated under reduced pressure and freeze-dried to improve The problem of high blood pressure in Chinese people. The angiotensin-converting enzyme inhibitor activity analysis of this example is the same as that of the first embodiment, and is carried out by the calculation of the formula 1. Please refer to Fig. 4, which is the effect of different concentrations of the Fr.10 sample on the angiotensin-converting enzyme activity, and its IC 50 value can be calculated from its regression line to be 383.7 μg/ml.

第2表:各區分物之ACEi活性Table 2: ACEi activity of each component

請參照第5圖所示,為該區分物Fr.10的氣相層析分析結果,本發明係選用Varian 450-GC與Varian 240-MS系統(Varian,USA)的氣相層析質譜儀(GC-Mass)、VF-5ms管柱(30 m×0.25 mm,0.25 μm,FactorFourTM ,USA),以氦氣做為載流氣體,在氣體流率設定為每分鐘1.0毫升(ml)、分流率為10:1、注射口溫度設為250℃等條件下,進行分析。其中,該管柱的溫度變化係設定50℃維持5分鐘,其後以每分鐘上升5℃的速率將溫度升至120℃且在120℃維持8分鐘,再以每分鐘上升8℃的速率將溫度升至200℃,最後以每分鐘上升3℃的速率將溫度升至300℃,且維持10分鐘。質譜收集範圍設定為50-650 a.m.u,並使電子脈衝電壓為10e。所得的結果可登錄National Institute of Standards and Technology(NIST MS 2.0 database,USA)資料庫,進一步鑑定其活性成分。Referring to Fig. 5, for the gas chromatographic analysis of the distinguishing material Fr. 10, the present invention selects a Varian 450-GC and a Varian 240-MS system (Varian, USA) for gas chromatography mass spectrometry ( GC-Mass), VF-5ms column (30 m × 0.25 mm, 0.25 μm, FactorFour TM , USA) with helium as the carrier gas, set at a gas flow rate of 1.0 ml (ml) per minute, shunt The analysis was carried out under the conditions of a ratio of 10:1 and an injection port temperature of 250 °C. Wherein, the temperature change of the column is set at 50 ° C for 5 minutes, then the temperature is raised to 120 ° C at a rate of 5 ° C per minute and maintained at 120 ° C for 8 minutes, and then at a rate of 8 ° C per minute. The temperature was raised to 200 ° C and finally the temperature was raised to 300 ° C at a rate of 3 ° C per minute and maintained for 10 minutes. The mass spectrometry collection range was set to 50-650 amu and the electron pulse voltage was 10e. The results obtained can be further verified in the National Institute of Standards and Technology (NIST MS 2.0 database, USA) database.

請參照第3表所示,經氣相層析質譜儀分析圖譜之鑑定,顯示該區分物Fr.10中至少包含13種化合物,其中又以Octadecanoic acid、Hexadecanoic acid及其酯類化合物居多,相對含量約佔總量的60%。Please refer to the table 3 for the identification of the analysis by gas chromatography mass spectrometry. It shows that the Fr.10 contains at least 13 compounds, of which Octadecanoic acid, Hexadecanoic acid and its esters are mostly The content accounts for about 60% of the total.

第3表:區分物Fr.10的化學成分分析結果Table 3: Chemical composition analysis results of the classification Fr.10

請參照第6圖所示,係該區分物Fr.10所呈現的藥物動力學分析結果,其呈現該區分物Fr.10係為競爭型阻害之抑制型態。Please refer to Fig. 6 for the pharmacokinetic analysis results presented by the reference Fr. 10, which shows that the Fr. 10 line is a competitive inhibition type.

承上所述,本發明之土半夏葉萃取物,係具有良好的血管收縮素轉化酶抑制活性,因此具有降血壓、預防心血管疾病之功效,可作為高血壓輔助治療劑或保健食品。該土半夏葉萃取物可以單獨使用於相關輔助治療劑或保健食品之開發,或者搭配醫藥學上可接受之載劑、賦形劑或其他營養成分等而組合一複合物。其中,該土半夏葉萃取物係可以製備成任何方便食用之型式,如錠劑、膠囊、粉劑、粒劑或液劑等,或者將該土半夏葉萃取物與其他食品或飲料組合,進一步加工製成更適於食用之食品樣態以供口服方式服用。According to the above, the soil of the summer leaves of the present invention has good angiotensin-converting enzyme inhibitory activity, and thus has the effects of lowering blood pressure and preventing cardiovascular diseases, and can be used as an auxiliary therapeutic agent for hypertension or a health food. The soil Pinellia ternata extract may be used alone in the development of related adjuvant therapeutics or health foods, or may be combined with a pharmaceutically acceptable carrier, excipient or other nutrient composition. Wherein, the soil summer leaf extract system can be prepared into any convenient edible form, such as a tablet, a capsule, a powder, a granule or a liquid agent, or the soil of the Pinellia ternata extract is combined with other foods or beverages for further processing. Make a more food-like form for consumption for oral administration.

本發明之土半夏葉萃取物,係具有良好的血管收縮素轉化酶抑制劑活性,可經由簡便的萃取步驟而製得,可應用於降血壓相關輔助治療劑或保健食品之研發,以改善現代人高血壓之問題,為本發明之功效。The soil summer leaf extract of the invention has good angiotensin-converting enzyme inhibitor activity and can be prepared through a simple extraction step, and can be applied to the research and development of blood pressure-related auxiliary therapeutic agents or health foods to improve modernity. The problem of human hypertension is the efficacy of the present invention.

雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.

S1...第一萃取步驟S1. . . First extraction step

S2...第二萃取步驟S2. . . Second extraction step

S3...第三萃取步驟S3. . . Third extraction step

S4...第一萃取步驟S4. . . First extraction step

S5...第二萃取步驟S5. . . Second extraction step

S6...第三萃取步驟S6. . . Third extraction step

S7...管柱層析步驟S7. . . Column chromatography step

第1圖:本發明第一實施例之土半夏葉萃取物的萃取方法。Fig. 1 is a view showing the extraction method of the soil summer leaf extract of the first embodiment of the present invention.

第2圖:本發明第一實施例之土半夏葉萃取物的ACEi活性分析圖。Fig. 2 is a graph showing the analysis of ACEI activity of the Pinellia ternata extract of the first embodiment of the present invention.

第3圖:本發明第二實施例之土半夏葉萃取物的萃取方法。Fig. 3 is a view showing the extraction method of the soil summer leaf extract of the second embodiment of the present invention.

第4圖:本發明第二實施例之區分物Fr.10的ACEi活性分析圖。Fig. 4 is a graph showing the analysis of the ACEI activity of the distinguishing substance Fr. 10 of the second embodiment of the present invention.

第5圖:本發明第二實施例之區分物Fr.10的氣相層析質譜分析圖。Fig. 5 is a gas chromatographic mass spectrometry diagram of the distinguishing material Fr. 10 of the second embodiment of the present invention.

第6圖:本發明第二實施例之區分物Fr.10的酵素動力學抑制型態。Fig. 6 is a diagram showing the enzyme kinetic inhibition type of the distinguishing substance Fr. 10 of the second embodiment of the present invention.

S1...第一萃取步驟S1. . . First extraction step

S2...第二萃取步驟S2. . . Second extraction step

S3...第三萃取步驟S3. . . Third extraction step

Claims (11)

一種土半夏葉萃取物,係藉由一包含下列步驟之方法所製得:一第一萃取步驟,係使用乙醇作為萃取溶劑,對土半夏葉進行萃取處理,使該土半夏葉與該乙醇之重量體積比(w/v,g/ml)為1:4至1:10,並回收乙醇萃取液,再濃縮與冷凍乾燥該乙醇萃取液而獲得一第一萃取物;一第二萃取步驟,係使用等體積之乙醇與正己烷作為萃取溶劑,對該第一萃取步驟所得之第一萃取物進行萃取處理,靜置分層後取乙醇層,經減壓濃縮與冷凍乾燥而獲得一第二萃取物,其中,該第一萃取物與該第二萃取步驟之萃取溶劑的重量體積比為1:1至1:10;及一第三萃取步驟,係於該第二萃取物中加入等體積之水與乙酸乙酯作為萃取溶劑,對該第二萃取物進行萃取處理,靜置分層後取乙酸乙酯層,經減壓濃縮與冷凍乾燥而獲得該土半夏葉萃取物,其中,該第二萃取物與該第三萃取步驟之萃取溶劑的重量體積比為1:1至1:10。A soil Pinellia ternata extract is prepared by a method comprising the following steps: a first extraction step of extracting the soil of Pinellia ternata using ethanol as an extraction solvent to make the soil of the summer leaves and the ethanol The weight-to-volume ratio (w/v, g/ml) is 1:4 to 1:10, and the ethanol extract is recovered, and the ethanol extract is concentrated and lyophilized to obtain a first extract; a second extraction step, The first extract obtained in the first extraction step is subjected to extraction treatment by using an equal volume of ethanol and n-hexane as an extraction solvent, and the layer is separated after standing, and the ethanol layer is taken, concentrated under reduced pressure and freeze-dried to obtain a second. The extract, wherein the weight ratio of the first extract to the extraction solvent of the second extraction step is 1:1 to 1:10; and a third extraction step is to add an equal volume to the second extract. The second extract is subjected to extraction treatment by using water and ethyl acetate as an extraction solvent, and the layer is separated, and then the ethyl acetate layer is taken, and concentrated under reduced pressure and freeze-dried to obtain the soil extract of Pinellia ternata, wherein Second extract and the third extraction step Weight to volume ratio of extraction solvent is from 1: 1 to 1:10. 如申請專利範圍第1項所述之土半夏葉萃取物,其中,該方法更包含一管柱層析步驟,係於該第三萃取步驟之後操作,將該第三萃取步驟之土半夏葉萃取物,利用一矽膠管柱,依序以正己烷和乙酸乙酯,以及乙酸乙酯和甲醇作為流動相,進行層析分離處理,分瓶收集洗滌液,再以薄膜色層分析該洗滌液,合併成份相同之洗滌液,以獲得數個區分物,該區分物係依洗滌先後而編號為Fr.1至Fr.10,擷選該Fr.10經減壓濃縮及冷凍乾燥後,即得該土半夏葉萃取物。The method of claim 19, wherein the method further comprises a column chromatography step, after the third extraction step, the soil of the third extraction step is extracted from the summer leaves. The product was subjected to chromatographic separation using a column of a rubber tube, followed by n-hexane and ethyl acetate, and ethyl acetate and methanol as a mobile phase, and the washing liquid was collected in a vial, and the washing liquid was analyzed by a film color layer. The washing liquids having the same composition are combined to obtain a plurality of distinguishing substances, which are numbered according to the washing order and are numbered as Fr.1 to Fr.10, and the Fr.10 is selected and concentrated under reduced pressure and freeze-dried. Soil pinellia leaf extract. 如申請專利範圍第2項所述之土半夏葉萃取物,其中,該管柱層析步驟,係擷選該Fr.2經減壓濃縮及冷凍乾燥後,即得該土半夏葉萃取物。The soil summer leaf extract according to claim 2, wherein the column chromatography step is performed after the Fr. 2 is concentrated under reduced pressure and freeze-dried to obtain the soil summer leaf extract. 如申請專利範圍第2項所述之土半夏葉萃取物,其中,該管柱層析步驟中,係利用不同比例正己烷和乙酸乙酯混合液作為流動相,其中該正己烷與該乙酸乙酯的混合比例由100%正己烷,依序以每次10%之比例逐漸改變為1:9,接著以不同比例乙酸乙酯和甲醇混合液作為流動相,其中該乙酸乙酯和甲醇的混合比例由100%乙酸乙酯,依序以每次10%之比例逐漸改變比例至100%甲醇,以進行層析區分分離。The soil summer leaf extract according to claim 2, wherein the column chromatography step uses a mixture of different ratios of n-hexane and ethyl acetate as a mobile phase, wherein the n-hexane and the acetic acid B The mixing ratio of the ester is gradually changed from 100% n-hexane to 10% in the ratio of 1:9, followed by a mixture of ethyl acetate and methanol in different proportions as a mobile phase, wherein the mixture of ethyl acetate and methanol is mixed. The ratio was gradually changed from 100% ethyl acetate to 10% methanol in the order of 10% each time for chromatographic separation. 如申請專利範圍第4項所述之土半夏葉萃取物,其中,各比例之流動相係以500毫升之體積依序通入該矽膠管柱,再於該矽膠管柱下方分瓶收集洗滌液,每瓶所收的洗滌液量為250毫升。The soil summer leaf extract according to claim 4, wherein the liquid phase of each ratio is sequentially introduced into the rubber tube column in a volume of 500 ml, and the washing liquid is collected in a bottle under the rubber tube column. The amount of washing liquid collected per bottle is 250 ml. 如申請專利範圍第1項所述之土半夏葉萃取物,其中該第一萃取步驟之萃取溶劑係50%至95%之乙醇。The soil summer leaf extract according to claim 1, wherein the extraction solvent of the first extraction step is 50% to 95% ethanol. 如申請專利範圍第1項所述之土半夏葉萃取物,其中,該第一萃取步驟、第二萃取步驟及第三萃取步驟係操作於攪拌速率為100至1000 rpm、25℃至70℃之環境,重覆萃取1至3次,每次萃取30分鐘以上。The soil summer leaf extract according to claim 1, wherein the first extraction step, the second extraction step and the third extraction step are operated at a stirring rate of 100 to 1000 rpm, 25 to 70 ° C. Environment, repeated extraction 1 to 3 times, each extraction for more than 30 minutes. 如申請專利範圍第7項所述之土半夏葉萃取物,其中,該第一萃取步驟係重複萃取3次且每次萃取24小時。The soil summer leaf extract according to claim 7, wherein the first extraction step is repeated 3 times and extracted for 24 hours each time. 如申請專利範圍第7項所述之土半夏葉萃取物,其中,該第二萃取步驟係重複萃取3次且每次萃取3小時。The soil summer leaf extract according to claim 7, wherein the second extraction step is repeated 3 times and extracted for 3 hours each time. 如申請專利範圍第7項所述之土半夏葉萃取物,其中,該第三萃取步驟係重複萃取3次且每次萃取3小時。The soil summer leaf extract according to claim 7, wherein the third extraction step is repeated 3 times and extracted for 3 hours each time. 一種如申請專利範圍第1或2項所述之土半夏葉萃取物的用途,係將該土半夏葉萃取物作為一活性物質,應用於製備用以改善高血壓的輔助治療劑或保健食品。The use of the soil summer leaf extract as described in claim 1 or 2, which is applied as an active substance to prepare an adjuvant therapeutic or health food for improving hypertension.
TW101107225A 2012-03-03 2012-03-03 Extract of leaves of typhonium blumei nicolson & sivadasan and its use TWI410248B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101107225A TWI410248B (en) 2012-03-03 2012-03-03 Extract of leaves of typhonium blumei nicolson & sivadasan and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101107225A TWI410248B (en) 2012-03-03 2012-03-03 Extract of leaves of typhonium blumei nicolson & sivadasan and its use

Publications (2)

Publication Number Publication Date
TW201336501A TW201336501A (en) 2013-09-16
TWI410248B true TWI410248B (en) 2013-10-01

Family

ID=49627604

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101107225A TWI410248B (en) 2012-03-03 2012-03-03 Extract of leaves of typhonium blumei nicolson & sivadasan and its use

Country Status (1)

Country Link
TW (1) TWI410248B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI823110B (en) * 2020-07-02 2023-11-21 國立清華大學 Use of thearaceae extract for regeneration of neurons

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Hsia-Fen Hsu et. al. Typhonium blumei extract inhibits proliferation of human lung adenocarcinoma A549 cells via induction of cell cycle arrest and apoptosis. Journal of Ethnopharmacology, 2011, Vol. 135, No. 2, p. 492-500 *
碩士論文,土半夏抗癌活性檢測與其作用機轉探討,盧桂汝,2007 *

Also Published As

Publication number Publication date
TW201336501A (en) 2013-09-16

Similar Documents

Publication Publication Date Title
US9301967B2 (en) Method for preparing pharmaceutical composition for enhancing immunity and pharmaceutical composition prepared according to the method
JP2007523144A (en) Botanical medicine for treating hepatitis C
CN101195647B (en) Hydroxyl carthamus tinctorius yellow colour A, preparation method and application thereof
KR101251589B1 (en) Method for preparing crude saponin composition enhanced purity and effective saponin contents from platycodon grandiflorum or the extract therefrom
CN104784235A (en) Method for preparing fresh ginsengfreeze-dried oral instant preparation
CN109528803B (en) Preparation method of radix pseudostellariae extract, radix pseudostellariae extract prepared by preparation method and detection method
CN108310021A (en) A kind of ganoderma lucidum spore oil extract dripping pill and preparation method thereof
CN113425757A (en) Dandelion extract and preparation method and application thereof
EP3064212B1 (en) Paliurus ramosissimus (lour.) poir extract and preparation method and uses thereof
TWI410248B (en) Extract of leaves of typhonium blumei nicolson &amp; sivadasan and its use
WO2020087687A1 (en) Isopentenyl chalcone compound and preparation method therefor
KR101766538B1 (en) A method for acquiring extract comprising polyphenols components from Rosae Multiflorae Fructus with high yield
CN106822331A (en) To lock application of the lichee bark extract based on shape polymer polyphenol in treatment antihyperuricemic disease drug or health products are prepared
JP4117029B2 (en) Harpagophytum Procumbens and / or extract extracted from Harpagophytum hei heridens, process for producing the same and use thereof
KR101881653B1 (en) Process for Extracts of Enhancing Blood Circulation from red bean shell and Compositions comprising the Extracts as an active ingredient
CN1209155C (en) Balsam pear products containing multiple hypoglycemic active composition and preparation thereof
CN106822071B (en) Chinese medicinal effective component for treating coronary heart disease and hyperlipidemia, its preparation method and method for separating effective component from the same
CN101955501A (en) Method for extracting and separating high-purity salidroside in pilot scale
JP4480204B2 (en) Anti-tumor fraction of Kawariharatake
CN112386654B (en) Traditional Chinese medicine composition, extract, preparation method and application thereof
CN103102376B (en) A kind of separation method concurrently separating Vaccarin and Semen Vaccariae total saponins
AU2021100283A4 (en) A method for extraction and purification of spermidine from animal tissues and its application
CN107308270A (en) A kind of anticancer pharmaceutical composition
KR20110012431A (en) Method for preparing crude saponin composition enhanced purity and effective saponin contents from platycodon grandiflorum or the extract therefrom
KR101100682B1 (en) Production Method for Extracts of Pleurotus cornucopiae with Antihypertensive action and the Extracts produced thereby, New purified ACE inhibitor and Food containing them

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees